Bliss GVS Pharma Limited — Earnings Release 2019

May 21, 2019

BLISS GVS PHARMA LTD. ~.s.s

May 21, 2019

T o	T o
h is ti T M L D tm t g e an ag er n ep ar en ,	h G al is ti T M L D tm t g e en er an ag er n ep ar en ,
io al S ck ch of di N E In at to n x an ge a	S im it ed B E L
G lo C ll lo ck P B t n o ,	P h ir Je ej bh T oy oz e ee ow er s,
dr la le dr B K C B (E t) an a- ur om p x an a as , ,	al al D S tr t, ee
b ai 4 00 0 5 1 M m u -	b ai 4 00 00 1 M m u -
S b ol B L IS S G V S ym :	S i C od 50 19 7 6 p cr e:

Subject: Newspaper Advertisement of Audited Financial Results for the quarter and year ended March 31, 2019

Dear SirIMadam,

Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of audited financial results of the Company for the quarter and year ended March 31, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' ^a Regional Daily, on May 21,2019.

Kindly take the same on record.

Thanking You,

Your Faithfully, For Bliss GVS Pharma Limited

Factory : Regd. Office: 102, Hyde Park, Saki Vihar Road,Andheri (East), Mumbai - 400072, INDIA. TEL. : (+91) (22) 42160000/ 28505387 • FAX.: (+91) (22) 28563930, Email: info@blissgvs.com • Website: www.blissgvs.com· CIN - L24230MH1984PLC034771 Plot NO.10 & 11Survey No. 38/1, Dewan Udyog Nagar,Aliyali Village, Tal. & Dist. Palghar- 401404.

Tel.(+91) (02525) ²⁵²⁷¹³ • Fax: (+91) (02525) 255257.• Email: factory@blissgvs.com

Note:

(1)The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter and Year ended March 31. 2019 and Annual Result for the Year ended March 31, 2019 are filed with the Stock Exchanges under RegulatiOn' 33 of the SEBI (Listing Obligations and Disclosure Hequlrernents) Regulations, 2015,The figures for the quarter ended March 31, 2019are the balancing figures between the audited figures in respect of the year ended March 31,2019 and unaudited figures in respect of the nine months ended December 31,2018.",

, (2) The full format ^o'fthe Standalone and Consolidated financial results for the Quarter and Year ended March 31, 2019 and Annual Result for the Year ended March 31,2018are available en the Stock Exchange websites - www.bseindia.comand wWw.nseindia,comand on the Company's website www.bllssqvs.corn.

(3)Theresults have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under section 133of the CorripanlesAct read v&ith relevant rules issued there under. ' ,

(4)The Board of Director in their meeting held on May 18,2019 have recommended dividend on', 1/- per equity share l.e., 100%for the F. Y 2018-19subject to approval of shareholders in the ensuing Annual General Meeting to be held on 20September, 2019,

THE FREE PRESS JOURNAL www.freepressjournal.in MUMBAI TUESDAY MAY 21, 2019			15
Bliss			BLISS GVS PHARMA LIMITED CIN No. - L24230MH1984PLC034771 Registered Office: 102, Hyde Park, Sakivihar Road, Andheri (East), Mumbai - 400 072.
EXTRACT OF STATEMENT OF AUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER AND YEAR ENDED MARCH 31, 2019
			STANDALONE
Total Income 1 49.51% ₹46,240.31 vs ₹30,928.88 PAT ₹7,443.39 vs ₹5,701.46	30.55%	EBITDA	5.24% ₹ 9,310 vs ₹ 8,846.52	EPS	30.56% ₹ 7.22 vs ₹ 5.53	PBT ₹ 12,001.33 vs ₹ 8,683.72	38.21%
		STANDALONE				CONSOLIDATED		(₹ in Lakhs)
Particulars	QUARTER ENDED 31.03.2019 (AUDITED)	YEAR ENDED 31.03.2019 (AUDITED)	YEAR ENDED 31.03.2018 (AUDITED)	QUARTER ENDED 31.03.2018 (AUDITED)	QUARTER ENDED 31.03.2019 (AUDITED)	YEAR ENDED 31.03.2019 (AUDITED)	YEAR ENDED 31.03.2018 (AUDITED)	QUARTER ENDED 31.03.2018 (AUDITED)
Total income from operations (net)	10,614.32	42,659.02	29,829.38	8,331.83	24,405.08	89,824.92	81,514.00	16,710.04
Net Profit / (Loss) from ordinary activities after tax	463.50	7,443.39	5,701.46	2,031.31	1,810.76	12,372.16	9,298.41	1,988.33
Net Profit / (Loss) from ordinary activities after tax, exceptional and extraordinary items	463.50	7,443.39	5,701.46	2,031.31	1,810.76	12,372.16	5,878.53	$(-1, 431.55)$
Total Comprehensive Income for the period	441.26	7,426.03	5,720.51	2,056.47	1,825.71	12,222.20	5,748.68	$(-1, 437.55)$
Equity Share Capital	1,031.47	1,031.47	1,031.47	1,031.47	1,031.47	1,031.47	1,031.47	1,031.47
Other Equity		59,295.89	53,110.75			63,568.39	52,592.46
Earnings Per Share Basic and Diluted (in ₹.)	0.45	7.22	5.53	1.97	1.76	11.99	5.70	$(-1.39)$

(1) The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter and Year ended March 31, 2019 and Annual Result for the Year ended March 31, 2019 are filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The figures for the quarter ended March 31, 2019 are the balancing figures between the audited figures in respect of the year ended March 31, 2019 and unaudited figures in respect of the nine months ended December 31, 2018."

(2) The full format of the Standalone and Consolidated financial results for the Quarter and Year ended March 31, 2019 and Annual Result for the Year ended March 31, 2018 are available on the Stock Exchange websites - www.bseindia.com and www.nseindia.com and on the Company's website www.blissgvs.com.

(3) The results have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under section 133 of the Companies Act read with relevant rules issued there under.

(4) The Board of Director in their meeting held on May 18, 2019 have recommended dividend of ₹. 1/- per equity share i.e., 100% for the F. Y 2018-19 subject to approval of shareholders in the ensuing Annual General Meeting to be held on 20 September, 2019.

		.', I ~	(~ ':. ~,	it I e di ':.(o ~O ,	t,m to nl in in e.	•	! .< . - ~ v· ~.
B L I R is te eg re	S S d O ff ic e	G V C IN N H yd 10 2 : ,	S P L 2 4 2 3 o .- P k, S ak e ar	H A R 0 M H 19 8 iv ih R ar oa	M A C 4 P L 0 3 4 d A nd he ,	L I M 7 7 1 ri (E t) M as ,	I T E ba i 40 um -	D · 00 72
% T l I t 4 9 .5 1 o a n c o m e 4 ,2 4 0 .3 1 3 0 2 8 .8 8 6 ,9 ~ ~ vs		,3 1 0 9 ~ vs	8 ,8 4 .5 6 ~	2	P 1 ~	B T 2 ,0 0 1 .3 3	% 3 8 .2 1 8 8 ,6 ~ vs	3 2 .7
A " P T ,4 4 3 .3 7 9 ~	% 3 0 .5 5 5 0 ,7 ~ vs	1 .4 6	E	S " P .2 2 7 ~	% 3 0 .5 6 5 .5 3 ~ vs
						'
Pa rti la cu rs	Q UA RT ER EN DE D 31 .03 .20 19 (A UD IT ED	YE AR EN DE D 31 .03 .20 19 ) (A UD IT ED	YE AR EN DE D 31 .03 .20 18 ) (A UD IT ED	Q UA RT ER EN DE D 31 .03 .20 18 ) (A UD IT ED	Q UA RT ER EN DE D 31 .03 .20 19 ) (A UD IT ED )·	YE AR EN DE D 31 .03 .20 19 (A UD IT ED )	YE AR EN DE D 31 .03 .20 18 (A UD IT ED	Q UA RT ER EN DE D 31 .03 .20 18 ) (A UD IT ED
al in fro io (n ) ot at et co m e m op er ns	10 ,6 14 .3 2	42 ,6 59 .0 2	29 ,8 29 .3 8	8, 33 1. 83	,2 4, 40 5. 08	89 ,8 24 .9 2	81 ,5 14 .0 0	16 ,7 10 .0
Pr of itt (L s) fro di tiv itie fte et os m or na ry ac sa r		44 3. 39 7,	5, 70 1. 46	2, 03 1	1, 81 0. 76		9, 29 8. 41	1, 98 8. 33
Pr of itt (L s) fro di tiv itie fte t rta os m or na ry ac sa x, pt io l d tra di ite ce na an ex or na ry m s	46 3. 50	44 3. 39 7,	70 1. 46 5,	2, 03 1. 31	1, 81 0. 76	12 ,3 72 .1 6	87 8. 53 5,	(-1 ,4 31 5) .5
lC eh siv in fo th rio d ta om pr en e co m e r e pe	44 1. 26		5, 72 0. 51	2, 05 6. 47	1, 82 5. 71	12 ,2 22 .2 0	5, 74 8. 68	(-1 5) ,4 37 .5
Sh Ca uit pit al y ar e	1, 03 1. 47	1, 03 1. 47	1, 03 1. 47	1, 03 1. 47	1, 03 1. 47	1, 03 1. 47	1, 03 1. 47	1, 03 1. 47
th Eq uit er y		59 ,2 95 .8 9	53 ,1 10 .7 5			63 68 .3 9 ,5	52 92 .4 6 ,5
, T ':N Ne ex To Eq O Pe Sh r ar e

(2) The full fermat of the Standalone and Consolidated financial resultsfor the Quarter and Yearended March 31, 2019 and Annual Result for the Yearended March 31, 2018are available on theStockExchangewebsites -www.bseindia.com and www.nseindia.com and on the Company'swebsite www.blissgvs.com. (3) The results have been prepared inaccordance with the IndianAccounting Standards (Ind AS) as prescribed under section 133of the Companies Act readwith relevant rulesissued there under.

(4) The Board of Director in their meetingheld on May 18,2019 have recommended dividend of~. 1/- per equity share i.e., 100%for the F. Y ,2018-19subject to approval of shareholders in the ensuingAnnualGeneralMeetingto be held on 20 September, 2019.

For and on behalf of the Board of Directors SD/- . S. N. KAMATH f'{IANAGING DIRECTOR Q

(1)The' above is an extract of the detailed format of the Standalone and Consolidated financial resultsfor the Quarter and Year ended March 31, 2019 and Annual Result fpr the Year ended March 31, 2019 are filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) R.egulations,2015.The figures for the quarter ended March 31, 2019 are the balancing figures between the audited figures in respect of the year ended March31,2019 and unauditedfigures in respect ofthe nine-monthsended December 31,2018." .

(2) The full format of the Standalone and Consolidated financial resultsfor the Quarter and Yearended March 31, 2019 and Annual Resultfor the Yearended March 31,2018 are availableon the Stock Exchangewebsites -www.bseindia.com and www.nseindia.com and on the Company'swebsite www.blissgvs.com. (3)The results have been prepared in accordance with the IndianAccounting Standards (Ind AS) as prescribed under section 133of the Companies Act readwith relevant rules issued there under. .

(4) The Board of Director in their meeting held on May 18.,2019 have recommended dividend of ~. 1/- per equity share i.e., 100%for the F. Y 2018-19 subject to approval of shareholders in the ensuingAnnual General Meetingto be held on 20 September,2019. .